Clot-busting drug alteplase shows promise for stroke treatment up to 24 hours after onset

The clot-dissolving medication, alteplase, improved stroke patients' recovery by more than 50% when given up to 24 hours after the beginning of an ischemic stroke, according to preliminary late-breaking science…

Continue ReadingClot-busting drug alteplase shows promise for stroke treatment up to 24 hours after onset

Understanding the role of alternative splicing in cardiovascular diseases

Announcing a new article publication for Cardiovascular Innovations and Applications journal. Alternative splicing (AS), a critical process for gene expression regulation, allows a single precursor RNA to produce multiple transcript…

Continue ReadingUnderstanding the role of alternative splicing in cardiovascular diseases